HERBOSOMES - A NOVEL DRUG DELIVERY CARRIER FOR ENHANCED BIOAVAILABILITY OF HERBAL EXTRACTS

Read full text Summarise with VIRAT
Authors: V. Anusha*, R. Kusuma, B. Swathi, N. Rajani, Aruna Kuthani
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Herbal treatments also consistently and significantly contribute to the development of human health in comparison with allopathic treatments. From ancient times, herbal preparations were considered as the most essential type of medicine in all the civilizations. The numerous plant extracts have exhibited an extensive range of biological activity, like immunomodulator activity, hepatoprotective activity, antilipidemic action, etc. Herbal extracts obtained from plants demonstrate great in vitro bioactivity and exhibits low in vivo action in animal models. The foremost explanations for this behavior is that the bioactive components have the composition that cannot be permeated by simple passive diffusion, and most of the phytoconstituents are polar water soluble compounds, which results in their poor lipid solubility. This issue can be resolved by formulation of herbosomes which are the novel lipid based drug delivery system which delivers the herbal extract at the targeted site of activity with improved absorption, bioavailability and efficacy. They assists to overcome the challenges of bioavailability issues by forming herbososme complex. They include complex comprising herbal natural extract with suitable phospholipids like phosphatidylcholine and phosphatidylserine, etc. This advanced technique has been developing as an approach to enhance the medicinal potential of plant based extracts. Key words: Herbosomes, phospholipids, bioavailability, phytomedicines, phytoconstituents

Fields of Study & Subjects

Advancements in Transdermal Drug Delivery Drug Solubulity and Delivery Systems Pharmacology and Nanomedicine Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
22 March 2026
Language
EN